Par Pharmaceutical
develops, manufactures and markets generic and branded specialty pharmaceutical products in the United States... Read morePar Pharmaceutical
develops, manufactures and markets generic and branded specialty pharmaceutical products in the United States... Read more
CEO
Add
News
Mar 26, 2024
Cision Canada
Par Pharmaceutical: Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS
Mar 14, 2024
Pharmabiz
Par Pharmaceutical: Par Pharma voluntarily recalls one lot of Treprostinil injection due to potential for silicone particulates in product solution
Nov 02, 2023
FinanzNachrichten
Par Pharmaceutical: Endo International plc: Endo Launches Colchicine Capsules, Generic Version of MITIGARE
Apr 26, 2023
StreetInsider
Press Release: Par Pharmaceutical : Endo Announces Agreement with Slayback Pharma to Distribute Prevduo (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination
Apr 10, 2023
Drug Store News
Par Pharmaceutical: Par launches authorized generic of Noxafil
Mar 17, 2023
Drug Store News
Par Pharmaceutical: Par launches generic Pylera
Feb 22, 2023
Law 360
Par Pharmaceutical: End Payors Latest To Drop Bankruptcy-Blocked Par Claims
Feb 09, 2022
The Hindu
Par Pharmaceutical: DRL unveils Vasostrict generic in U.S.
Jan 13, 2022
Drug Store News
Par Pharmaceutical: Par launches generic Cuvposa
Dec 16, 2021
firstwordpharma
Par Pharmaceutical: Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
Par Pharmaceutical Competitors
1
2
3
4
5
6
7
8
9
10